Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 13 | 2023 | 552 | 1.780 |
Why?
|
| Autoimmunity | 10 | 2021 | 221 | 1.320 |
Why?
|
| Receptors, Antigen, B-Cell | 6 | 2017 | 58 | 1.210 |
Why?
|
| Autoimmune Diseases | 5 | 2019 | 222 | 1.170 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2023 | 158 | 1.100 |
Why?
|
| Toll-Like Receptor 9 | 7 | 2023 | 196 | 0.990 |
Why?
|
| Lymphocyte Activation | 9 | 2023 | 739 | 0.970 |
Why?
|
| Antibodies, Antinuclear | 3 | 2022 | 36 | 0.960 |
Why?
|
| Interferon Type I | 3 | 2019 | 168 | 0.800 |
Why?
|
| Toll-Like Receptor 7 | 4 | 2023 | 96 | 0.690 |
Why?
|
| Nucleic Acids | 2 | 2019 | 50 | 0.660 |
Why?
|
| Toll-Like Receptors | 3 | 2016 | 434 | 0.590 |
Why?
|
| Inflammation | 4 | 2023 | 1106 | 0.570 |
Why?
|
| Rheumatoid Factor | 2 | 2015 | 13 | 0.560 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 113 | 0.410 |
Why?
|
| Interferon Regulatory Factors | 3 | 2021 | 39 | 0.410 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 157 | 0.360 |
Why?
|
| Mice | 19 | 2023 | 10309 | 0.360 |
Why?
|
| Endodeoxyribonucleases | 4 | 2019 | 40 | 0.350 |
Why?
|
| DNA | 5 | 2017 | 793 | 0.350 |
Why?
|
| Mice, Knockout | 11 | 2017 | 1997 | 0.340 |
Why?
|
| Autoantibodies | 5 | 2023 | 175 | 0.330 |
Why?
|
| Animals | 23 | 2023 | 19722 | 0.330 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2009 | 1 | 0.330 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2009 | 10 | 0.320 |
Why?
|
| RNA Editing | 1 | 2009 | 21 | 0.320 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 49 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 5 | 2016 | 880 | 0.310 |
Why?
|
| Mice, Transgenic | 6 | 2015 | 1225 | 0.300 |
Why?
|
| Autoantigens | 4 | 2023 | 125 | 0.290 |
Why?
|
| Cell Differentiation | 5 | 2017 | 1297 | 0.250 |
Why?
|
| Flow Cytometry | 6 | 2016 | 638 | 0.240 |
Why?
|
| B-Cell Activating Factor | 2 | 2017 | 9 | 0.230 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 14 | 0.220 |
Why?
|
| Platelet Factor 4 | 1 | 2023 | 11 | 0.220 |
Why?
|
| Bone Resorption | 1 | 2023 | 49 | 0.210 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 59 | 0.210 |
Why?
|
| Membrane Proteins | 3 | 2016 | 843 | 0.190 |
Why?
|
| Virus Diseases | 1 | 2012 | 111 | 0.180 |
Why?
|
| Influenza A virus | 1 | 2021 | 117 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2019 | 548 | 0.170 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 26 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2021 | 309 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 20 | 0.170 |
Why?
|
| Exodeoxyribonucleases | 1 | 2019 | 28 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 325 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2021 | 193 | 0.160 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 58 | 0.160 |
Why?
|
| Interferon-beta | 1 | 2009 | 76 | 0.160 |
Why?
|
| Immunity, Innate | 2 | 2021 | 768 | 0.160 |
Why?
|
| Th1 Cells | 1 | 2019 | 175 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 619 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 201 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 584 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2015 | 942 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2019 | 212 | 0.150 |
Why?
|
| Endosomes | 2 | 2016 | 169 | 0.150 |
Why?
|
| Ligands | 4 | 2023 | 421 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 5 | 0.140 |
Why?
|
| Antigens | 1 | 2017 | 146 | 0.130 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 29 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 1011 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 678 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2016 | 92 | 0.130 |
Why?
|
| CD2 Antigens | 1 | 2005 | 2 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2016 | 65 | 0.130 |
Why?
|
| CD3 Complex | 1 | 2005 | 64 | 0.120 |
Why?
|
| Arthritis | 1 | 2015 | 50 | 0.120 |
Why?
|
| Syndecan-1 | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2016 | 249 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2009 | 506 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2015 | 48 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 273 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2007 | 968 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 291 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2099 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 525 | 0.110 |
Why?
|
| Mice, Inbred CBA | 1 | 2013 | 82 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3207 | 0.110 |
Why?
|
| Dendritic Cells | 2 | 2015 | 508 | 0.110 |
Why?
|
| Humans | 9 | 2023 | 59817 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 64 | 0.100 |
Why?
|
| RNA | 1 | 2015 | 405 | 0.100 |
Why?
|
| Transcriptome | 1 | 2015 | 334 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2079 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 232 | 0.090 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2009 | 9 | 0.080 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2009 | 10 | 0.080 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 2009 | 13 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2007 | 80 | 0.080 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2009 | 32 | 0.080 |
Why?
|
| Complementarity Determining Regions | 1 | 2009 | 37 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1136 | 0.080 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2008 | 5 | 0.080 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2015 | 45 | 0.070 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2007 | 12 | 0.070 |
Why?
|
| Chromatin | 2 | 2023 | 598 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2007 | 193 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 236 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 121 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 449 | 0.060 |
Why?
|
| Male | 4 | 2021 | 27771 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2023 | 51 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 85 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 207 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 109 | 0.050 |
Why?
|
| Female | 4 | 2021 | 31100 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 761 | 0.050 |
Why?
|
| Nasal Lavage | 1 | 2021 | 2 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2023 | 205 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2023 | 150 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2023 | 156 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1539 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 12 | 0.050 |
Why?
|
| Germinal Center | 1 | 2021 | 37 | 0.050 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 94 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2015 | 99 | 0.050 |
Why?
|
| Thymus Gland | 2 | 2007 | 222 | 0.050 |
Why?
|
| Phenotype | 2 | 2015 | 1154 | 0.040 |
Why?
|
| Cell Survival | 1 | 2012 | 557 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2010 | 49 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 641 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 446 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 2891 | 0.040 |
Why?
|
| CD40 Antigens | 1 | 2017 | 60 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 40 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 78 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 14 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
|
| Terpenes | 1 | 2016 | 25 | 0.030 |
Why?
|
| Spleen | 2 | 2008 | 486 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2016 | 57 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 5 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2015 | 23 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 201 | 0.030 |
Why?
|
| Cytokines | 1 | 2009 | 909 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 498 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2015 | 91 | 0.030 |
Why?
|
| Interferons | 1 | 2015 | 63 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 303 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2015 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 60 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 667 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 15882 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1307 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2008 | 18 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 2008 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 112 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 180 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 26 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2008 | 174 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2007 | 76 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 129 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 145 | 0.020 |
Why?
|
| Transgenes | 1 | 2007 | 176 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2006 | 32 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 52 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 2464 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 453 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1040 | 0.010 |
Why?
|